XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net Income (Loss) $ (18,748,000) $ (50,582,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 7,862,000 8,844,000
Amortization of debt issuance costs 1,647,000 1,809,000
Amortization of interest on contract liabilities 578,000 719,000
Accrued interest on convertible notes, related party 2,640,000 2,400,000
Amortization of core premiums paid to customers 7,310,000 7,627,000
Amortization of finished goods premiums paid to customers 703,000 575,000
Noncash lease expense 7,265,000 7,614,000
Foreign exchange impact of lease liabilities and forward contracts 18,966,000 (2,659,000)
Change in fair value of compound net derivative liability (2,460,000) 1,690,000
Gain on short-term investments (126,000) (237,000)
Net provision for inventory reserves 11,317,000 9,637,000
Net provision for customer payment discrepancies and credit losses 324,000 1,112,000
Deferred income taxes (3,479,000) 29,721,000
Share-based compensation expense 3,009,000 4,268,000
(Gain) loss on disposal of plant and equipment (6,000) 9,000
Changes in operating assets and liabilities:    
Accounts receivable 12,475,000 26,272,000
Inventory 17,546,000 (46,558,000)
Prepaid expenses and other current assets (1,000,000) 5,316,000
Other assets (1,392,000) (392,000)
Accounts payable and accrued liabilities (22,854,000) 38,734,000
Customer finished goods returns accrual 2,637,000 (190,000)
Contract assets (18,031,000) (7,639,000)
Contract liabilities 18,300,000 15,561,000
Operating lease liabilities (6,754,000) (6,368,000)
Other liabilities (1,361,000) 1,162,000
Net cash provided by operating activities 36,368,000 48,445,000
Cash flows from investing activities:    
Purchase of plant and equipment (1,716,000) (462,000)
Proceeds for the sale of plant and equipment 49,000 0
Redemption of short-term investments 53,000 42,000
Net cash used in investing activities (1,614,000) (420,000)
Cash flows from financing activities:    
Borrowings under revolving loan 375,461,000 64,005,000
Repayments of revolving loan (408,659,000) (94,205,000)
Repayments of term loan 0 (13,125,000)
Payments for debt issuance costs (15,000) (2,617,000)
Payments on finance lease obligations (1,306,000) (1,425,000)
Cash used to net share settle equity awards (181,000) (279,000)
Repurchase of common stock (2,096,000) 0
Net cash used in financing activities (36,796,000) (47,646,000)
Effect of exchange rate changes on cash and cash equivalents (1,122,000) 180,000
Net (decrease) increase in cash and cash equivalents (3,164,000) 559,000
Cash and cash equivalents — Beginning of period 13,974,000 11,596,000
Cash and cash equivalents — End of period 10,810,000 12,155,000
Supplemental disclosures of cash flow information:    
Cash paid for interest, net 37,845,000 40,826,000
Cash paid for income taxes, net of refunds 4,338,000 8,143,000
Cash paid for operating leases 10,183,000 10,025,000
Cash paid for finance leases 1,446,000 1,595,000
Plant and equipment acquired under finance leases 684,000 33,000
Assets acquired under operating leases 2,512,000 879,000
Non-cash capital expenditures 144,000 71,000
Debt issuance costs included in accounts payable and accrued liabilities $ 0 $ 1,340,000